As per our analysis, the telemedicine market in Europe is estimated to grow from USD 11.32 billion in 2021 to USD 21.80 billion by 2026, with a compound annual growth rate (CAGR) of 14% over the next five years.
The significant factors contributing to the growth of the European telemedicine market are high literacy rate, rise in population of elderly patients, better socio-economic conditions, increase in the rate of chronic diseases, increase in adoption of IT solutions in healthcare, rise in demand for basic care services, the emergence of favorable policies and advancements in telecommunications.
Unavailability of internet services in rural areas, lack of awareness, and increased costs for the installation of telemedicine solutions are the limiting factors that challenge the growth of the Europe Telemedicine market.
Integrating healthcare with advanced technologies like IoT and data analytics has increased the growth opportunities of the telemedicine market in the European region. Also, the emergence of home care devices and social platforms has improved communication between consumers and professionals for transferring information and physiological data. Home care devices can track the health status of patients and regularly update the data to professionals, leading to rising demand for these devices. Furthermore, the growing healthcare sector is leading to rising in the focus of the private and public organizations on developing advanced technologies for real-time patient monitoring owing to consistently growing cases of chronic diseases, heart failure, asthma, cardiopulmonary disorders for treating at home. Rapid developments and enhancements in immersive environments like nanotechnology, virtual reality, and haptic feedback are expected to boost the growth opportunities of the Europe Telemedicine market during the forecast period.
This research report on the European telemedicine market has been segmented and sub-segmented into the following categories:
By Type:
By Application:
By Delivery Mode:
By End-Users:
By Country:
The European telemedicine market is expected to hold the second-largest share in the global market during the forecast period. In Europe, Medical consultation services will remain the most regularly used form of telemedicine used by physicians for escalating the outreach of their medical advice. The telemonitoring segment will also enjoy an upward trend owing to the increasing diabetic and disabled population. European Union has begun to promote the use of telemedicine for improving healthcare access while saving resources. However, regulation and reimbursement for telemedicine in the European Union vary, and it is up to the Member States to decide. Given the lack of public reimbursement, the UK is one of the largest markets within the EU, where many people are privately insured.
The telemedicine market in the UK is projected to grow at a CAGR of 10.4% during the forecast period. An increasing number of cancer patients is a major driving factor for the market to grow. Rising awareness over telemedicine in every corner of the country is lavishing the market's growth rate in this country. Government investments in the medical sector and to promote quality services even for the common people are propelling the demand of the UK telemedicine market. Growing focus on the construction of healthcare centers with the latest equipment is promoting the growth rate of this market to the extent.
The telemedicine market in Germany is promised to grow at a steady pace during the review period. Rising incidences of chronic diseases are greatly influencing the demand of the market to the extent. Also, acceptance of advanced technology and the launch of innovative devices favoring the end-users are promoting the demand of the German telemedicine market. Furthermore, continuous investments in the development of new technologies in research centers by government and non-government institutes are lavishing the growth rate of this market. Furthermore, escalating expenditure on healthcare is another most important factor for the market to grow in Germany.
It is expected that the telemedicine market in France is to hit the highest CAGR in the coming years. The increasing economy is one of the most common factors for the market to grow in this country. The adoption of telemedicine in France, along with growing awareness over the 4G and 5G spectrum, is ascribed to bolster the market demand. Artificial intelligence is playing a crucial role in the medical sector by solving complex issues more accurately. This is also enhancing the growth rate of the France telemedicine market. The trend towards early diagnosis of the disease is likely to outshine the demand of the market.
The telemedicine market in Spain is growing faster than the past few years and is to have significant growth opportunities in foreseen years. Increasing the prevalence of chronic and cardiovascular diseases is a key driving factor for the market to grow. On-going research on the development of new techniques in treating various diseases and growing to focus on artificial intelligence technology greatly influences the growth rate of the Spain telemedicine market. Rising disposable income and increasing expenditure on healthcare centers are boosting up the demand of the market. In addition, growing support from the IT sector is lavishing the growth rate of this market.
KEY MARKET PLAYERS:
A few of the prominent companies playing an active role in the European telemedicine market profiled in this report are AMD Global Telemedicine, CISCO Systems, Inc., Medtronic, Inc., GE Healthcare (U.K.), Honeywell Lifesciences, Philips healthcare, McKesson Corp, Aerotel Medical Systems, CardioComm, and Cerner Corporation.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Type
5.1.1 By Technology
5.1.1.1 Hardware
5.1.1.2 Software
5.1.1.3 Telecommunications
5.1.2 By Service
5.1.2.1 Tele-Monitoring
5.1.2.2 Store-and-Forward
5.1.2.3 Real-Time Interactive
5.3 By Applications
5.3.1 Tele-Cardiology
5.3.2 Tele-Radiology
5.3.3 Tele-Pathology
5.3.4 Tele-Dermatology
5.3.5 Tele-Neurology
5.3.6 Emergency Care
5.3.7 Home Health
5.3.8 Others
5.4 By Delivery Mode
5.4.1 Web-based
5.4.2 Cloud-based
5.4.3 Others
5.5 By End User
5.5.1 Tele-Hospitals
5.5.2 Tele-Homes
5.5.3 Others
6.1 Introduction
6.2 U.K
6.3 Germany
6.4 France
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AMD Telemedicine
8.3 CISCO Systems, Inc.
8.4 Medtronic, Inc.
8.5 Honeywell Lifesciences
8.6 Aerotel Medical Systems
8.7 Philips healthcare
8.8 McKesson Corp
8.9 Cerner Corporation
8.10 CardioComm
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
Related Reports
Apr 2021
